Health Dispatch Bio and CARsgen Launch Clinical Trial for Solid Tumors Dispatch Bio, a biotechnology firm focused on creating universal treatments for solid tumors, has entered into a clinical collaboration with CARSgen Therapeutics Holdings Limited.... Editorial12 January, 2026